Active Ingredient History
Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
---|
Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
---|
Anemia, Aplastic (Phase 2)
Anemia, Refractory (Phase 2)
Astrocytoma (Phase 1)
Brain Neoplasms (Phase 1)
Breast Neoplasms (Phase 2)
Burkitt Lymphoma (Phase 2)
Carcinoma, Renal Cell (Phase 2)
Chronic Disease (Phase 2)
Ependymoma (Phase 1)
Fanconi Anemia (Phase 2)
Glioblastoma (Phase 1)
Glioma (Phase 1)
Gliosarcoma (Phase 1)
Graft vs Host Disease (Phase 2)
Hematologic Neoplasms (Phase 2)
Hematopoietic Stem Cell Transplantation (Phase 2/Phase 3)
Hodgkin Disease (Phase 3)
Immunoglobulin Light-chain Amyloidosis (Phase 1/Phase 2)
Intraocular Lymphoma (Phase 2)
Kidney Neoplasms (Phase 2)
Leukemia (Phase 2)
Leukemia, Eosinophilic, Acute (Phase 2)
Leukemia, Hairy Cell (Phase 2)
Leukemia, Large Granular Lymphocytic (Phase 2)
Leukemia, Lymphocytic, Chronic, B-Cell (Phase 2)
Leukemia, Lymphoid (Phase 2)
Leukemia-Lymphoma, Adult T-Cell (Phase 2)
Leukemia, Mast-Cell (Phase 1/Phase 2)
Leukemia, Monocytic, Acute (Phase 2)
Leukemia, Myeloid (Phase 2/Phase 3)
Leukemia, Myeloid, Acute (Phase 3)
Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative (Phase 1/Phase 2)
Leukemia, Myeloid, Chronic-Phase (Phase 2)
Leukemia, Myelomonocytic, Chronic (Phase 2)
Leukemia, Myelomonocytic, Juvenile (Phase 2)
Leukemia, Neutrophilic, Chronic (Phase 2)
Lymphocytes (Phase 2)
Lymphoma (Phase 2/Phase 3)
Lymphoma, B-Cell, Marginal Zone (Phase 2)
Lymphoma, Follicular (Phase 2)
Lymphoma, Large B-Cell, Diffuse (Phase 2)
Lymphoma, Large-Cell, Anaplastic (Phase 2)
Lymphoma, Large-Cell, Immunoblastic (Phase 2)
Lymphoma, Mantle-Cell (Phase 2)
Lymphoma, Non-Hodgkin (Phase 3)
Lymphoma, T-Cell (Phase 2)
Lymphoma, T-Cell, Peripheral (Phase 2)
Lymphomatoid Granulomatosis (Phase 2)
Lymphoproliferative Disorders (Phase 3)
Mastocytosis (Phase 2)
Melanoma (Phase 2)
Meninges (Phase 1)
Meningioma (Phase 1)
Multiple Myeloma (Phase 2/Phase 3)
Myelodysplastic Syndromes (Phase 3)
Myeloproliferative Disorders (Phase 2/Phase 3)
Neoplasm, Residual (Phase 2)
Neoplasms (Phase 2)
Neoplasms, Plasma Cell (Phase 2)
Neuroblastoma (Phase 1)
Neuroectodermal Tumors, Primitive (Phase 1)
Neutropenia (Phase 1)
Oligodendroglioma (Phase 1)
Ovarian Diseases (Phase 1)
Ovarian Neoplasms (Phase 1)
Polycythemia Vera (Phase 2)
Precancerous Conditions (Phase 1/Phase 2)
Primary Immunodeficiency Diseases (Phase 1/Phase 2)
Primary Myelofibrosis (Phase 2)
Recurrence (Phase 2)
Sarcoma (Phase 2)
Severe Combined Immunodeficiency (Phase 1/Phase 2)
Sezary Syndrome (Phase 2)
Testicular Neoplasms (Phase 2)
Thrombocythemia, Essential (Phase 2)
Thrombocytopenia (Phase 2)
Transplantation (Phase 2)
Uterine Cervical Neoplasms (Phase 2)
Vaginal Neoplasms (Phase 2)
Vascular Grafting (Phase 2)
Waldenstrom Macroglobulinemia (Phase 2)
Trial | Phase | Start Date | Organizations | Indications |
---|
Feedback
Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).
Report issue